The Trump administration has successfully narrowed the FDA approval for the drug leucovorin, focusing on a rare genetic brain disorder. This move follows a rigorous review process that prioritized the…
The Trump administration has proposed a new FDA pathway to accelerate the approval of customized treatments for rare genetic diseases. This initiative, known as the plausible mechanism, allows for the…
Secretary Robert F. Kennedy Jr. is implementing a policy of radical transparency to rebuild trust in federal health agencies. The Department of Health and Human Services is streamlining data collection…
The Trump administration has successfully moved to regulate chest-compressing garments as medical devices through the Food and Drug Administration. Twelve companies have received formal warnings to stop marketing these products…
